304
Views
12
CrossRef citations to date
0
Altmetric
Original Articles

Vascular endothelial growth factor levels and bronchopulmonary dysplasia in preterm infants

, , , , & ORCID Icon
Pages 1517-1522 | Received 23 Sep 2019, Accepted 22 Apr 2020, Published online: 04 May 2020

References

  • Jensen EA, Dysart K, Gantz MG, et al. The diagnosis of bronchopulmonary dysplasia in very preterm infants: an evidence-based approach. Am J Respir Crit Care Med. 2019;200(6):751–759.
  • Stoll BJ, Hansen NI, Bell EF, et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics. 2010;126(3):443–456.
  • Northway WH, Jr., Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med. 1967;276(7):357–368.
  • Smith VC, Zupancic JAF, McCormick MC, et al. Trends in severe bronchopulmonary dysplasia rates between 1994 and 2002. J Pediatr. 2005;146(4):469–473.
  • Yen E, Weinberger BI, Laumbach RJ, et al. Exhaled breath condensate nitrite in premature infants with bronchopulmonary dysplasia. NPM. 2018;11(4):399–407.
  • Bhandari A, Bhandari V. Pitfalls, problems, and progress in bronchopulmonary dysplasia. Pediatrics. 2009;123(6):1562–1573.
  • Jobe AH. The new BPD. NeoReviews. 2006;7(10):e531–e545.
  • Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res. 1999;46(6):641–643.
  • Kunzmann S, Speer CP, Jobe AH, et al. Antenatal inflammation induced TGF-beta1 but suppressed CTGF in preterm lungs. Am J Physiol Lung Cell Mol Physiol. 2007;292(1):L223–31.
  • Thebaud B. Angiogenesis in lung development, injury, and repair: implications for chronic lung disease of prematurity. Neonatology. 2007;91(4):291–297.
  • Schneibel KR, Fitzpatrick AM, Ping X-D, et al. Inflammatory mediator patterns in tracheal aspirate and their association with bronchopulmonary dysplasia in very low birth weight neonates. J Perinatol. 2013;33(5):383–387.
  • Bose CL, Dammann CE, Laughon MM. Bronchopulmonary dysplasia and inflammatory biomarkers in the premature neonate. Arch Dis Child Fetal Neonatal Ed. 2008;93(6):F455–61.
  • Meller S, Bhandari V. VEGF levels in humans and animal models with RDS and BPD: temporal relationships. Exp Lung Res. 2012;38(4):192–203.
  • Sozo F, Ishak N, Bhatia R, et al. Surfactant phospholipid composition of gastric aspirate samples differs between male and female very preterm infants. Pediatr Res. 2017;82(5):839–849.
  • Ryan RM, Ahmed Q, Lakshminrusimha S. Inflammatory mediators in the immunobiology of bronchopulmonary dysplasia. Clinic Rev Allerg Immunol. 2008;34(2):174–190.
  • Brudno DS, Boedy RF, Kanto WP. Jr., Compliance, alveolar-arterial oxygen difference, and oxygenation index changes in patients managed with extracorporeal membrane oxygenation. Pediatr Pulmonol. 1990;9(1):19–23.
  • Lassus P, Ristimäki ARI, Ylikorkala O, et al. Vascular endothelial growth factor in human preterm lung. Am J Respir Crit Care Med. 1999;159(5):1429–1433.
  • Takahashi H, Shibuya M. The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clin Sci (Lond). 2005;109(3):227–241.
  • Meller S, Bhandari V. VEGF levels in humans and animal models with RDS and BPD: temporal relationships. Exp Lung Res. 2012;38(4):192–203.
  • Levesque BM, Kalish LA, Winston AB, et al. Low urine vascular endothelial growth factor levels are associated with mechanical ventilation, bronchopulmonary dysplasia and retinopathy of prematurity. Neonatology. 2013;104(1):56–64.
  • D’Angio CT, Maniscalco WM, Ryan RM, et al. Vascular endothelial growth factor in pulmonary lavage fluid from premature infants: effects of age and postnatal dexamethasone. Neonatology. 1999;76(5):266–273.
  • Been JV, Debeer A, van Iwaarden JF, et al. Early alterations of growth factor patterns in bronchoalveolar lavage fluid from preterm infants developing bronchopulmonary dysplasia. Pediatr Res. 2010;67(1):83–89.
  • Currie AE, Vyas JR, MacDonald J, et al. Epidermal growth factor in the lungs of infants developing chronic lung disease. Eur Respir J. 2001;18(5):796–800.
  • Bhatt A J, Pryhuber G S, Huyck H, et al. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;164(10):1971–1980.
  • D’Angio CT, Maniscalco WM. The role of vascular growth factors in hyperoxia-induced injury to the developing lung. Front Biosci. 2002;7:d1609–23.
  • Purohit A, Mehta R, Petrova A. Vascular endothelial growth factor (VEGF) in tracheal aspirates from preterm infants: effect of surfactant therapy. Arch Dis Childhood – Fetal Neonat Edn. 2011;96(Supplement 1):Fa30–Fa31.
  • Ishikawa M, Kitayama J, Kazama S, et al. Expression of vascular endothelial growth factor (VEGF)-C in preoperative biopsy specimens and metastatic foci of regional lymph nodes in submucosal gastric carcinoma. World J Surg Onc. 2005;3(1):2.
  • Farhath S, Aghai ZH, Nakhla T, et al. Pepsin, a reliable marker of gastric aspiration, is frequently detected in tracheal aspirates from premature ventilated neonates: relationship with feeding and methylxanthine therapy. J Pediatr Gastroenterol Nutrition. 2006;43(3):336–341.
  • Bry KJK, Jacobsson B, Nilsson S, et al. Gastric fluid cytokines are associated with chorioamnionitis and white blood cell counts in preterm infants. Acta Paediatr. 2015;104(6):575–580.
  • Schulz R, Hummel C, Heinemann S, et al. Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia. Am J Respir Crit Care Med. 2002;165(1):67–70.
  • Saugstad OD, Oei J-L, Lakshminrusimha S, et al. Oxygen therapy of the newborn from molecular understanding to clinical practice. Pediatr Res. 2019;85(1):20–29.
  • Kunig AM, Balasubramaniam V, Markham NE, et al. Recombinant human VEGF treatment transiently increases lung edema but enhances lung structure after neonatal hyperoxia. Am J Physiol Lung Cell Mol Physiol. 2006;291(5):L1068–78.
  • Capoluongo E, Vento G, Santonocito C, et al. Comparison of serum levels of seven cytokines in premature newborns undergoing different ventilatory procedures: high-frequency oscillatory ventilation or synchronized intermittent mandatory ventilation. Eur Cytokine Netw. 2005;16(3):199–205.
  • Pasha AB, Chen XQ, Zhou GP. Bronchopulmonary dysplasia: pathogenesis and treatment. Exp Ther Med. 2018;16(6):4315–4321.
  • Schreiber A, DI Marco F, Braido F, et al. High flow nasal cannula oxygen therapy, work in progress in respiratory critical care. Minerva Med. 2016;107(6 Suppl 1):14–20.
  • Paret G, Ziv T, Barzilai A, et al. Ventilation index and outcome in children with acute respiratory distress syndrome. Pediatr Pulmonol. 1998;26(2):125–128.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.